{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:07:07Z","timestamp":1788876427585,"version":"build-2803163510"},"reference-count":50,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["European J of Haematology"],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>While pediatric\u2010based protocols have significantly improved survival rates in adolescents and young adult (AYA) patients with Philadelphia\u2010negative acute lymphoblastic leukemia (Ph\u2010 ALL), limited information is available on the applicability of pediatric\u2010like chemotherapy in real life outside of clinical trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively collected clinical data from 36 AYA patients (median age 21\u2009years, range 18\u201338) with Ph\u2010 ALL (28) or lymphoblastic lymphoma (LL) (8) who received a frontline treatment inspired by the GIMEMA LAL1308 pediatric protocol in a multicenter real\u2010life setting, across centers participating in the Campus ALL network.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A morphologic or radiologic\/metabolic complete remission was documented in 31\/36 (86.1%) ALL\/LL patients after induction Phase Ib. Measurable residual disease (MRD) negativity was reached in 17\/23 (73.9%) evaluable ALL patients at the prognostic timepoint at the end of Ib induction cycle. Consolidation\/maintenance approaches followed risk\u2010adapted indications, with 20 (55.6%) patients receiving an allogeneic hematopoietic stem cell transplantation (allo\u2010HSCT) because of either adverse prognostic factors, resistance to induction treatment, morphologic relapse, or MRD positivity. The 5\u2010year overall, disease\u2010free, and event\u2010free survival rates were 76.4%, 69.1%, and 59%, respectively. No significant differences in outcomes were observed according to the ALL\/LL diagnosis, B\/T lineage, risk stratification, allo\u2010HSCT procedure, and, surprisingly, MRD status, probably due to the limited sample size or to optimal risk\u2010adapted and MRD\u2010driven intensification strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The implementation of this unmodified pediatric regimen to Ph\u2010 AYA ALL patients appears feasible in a real\u2010life context, with results that compare favorably to those of other pediatric\u2010based regimens not yet incorporating frontline immunotherapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/ejh.70317","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:11:33Z","timestamp":1788873093000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Outcomes of Younger Adults With Philadelphia\u2010Negative Acute Lymphoblastic Leukemia, Treated With A Pediatric\u2010Like Regimen Based on the GIMEMA LAL1308 Protocol. A Campus ALL Study"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6891-1420","authenticated-orcid":false,"given":"Fabio","family":"Forghieri","sequence":"first","affiliation":[{"name":"Department of Medical and Surgical Sciences, Section of Hematology University of Modena and Reggio Emilia, Azienda Ospedaliero\u2010Universitaria di Modena  Modena Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2953-7193","authenticated-orcid":false,"given":"Stefano","family":"Cordella","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, Section of Hematology University of Modena and Reggio Emilia, Azienda Ospedaliero\u2010Universitaria di Modena  Modena Italy"},{"name":"Clinical and Experimental Medicine PhD Program. Department of Biomedical, Metabolic and Neurosciences University of Modena and Reggio Emilia  Modena Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7568-9656","authenticated-orcid":false,"given":"Davide","family":"Lazzarotto","sequence":"additional","affiliation":[{"name":"Division of Hematology and Stem Cell Transplantation Azienda Sanitaria Universitaria Friuli Centrale (ASUFC)  Udine Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Annunziata","sequence":"additional","affiliation":[{"name":"Hematology Unit Hospital \u201cAntonio Cardarelli\u201d  Naples Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Lugli","sequence":"additional","affiliation":[{"name":"Hematology Unit Azienda USL \u2010 IRCCS di Reggio Emilia  Reggio Emilia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Ciccone","sequence":"additional","affiliation":[{"name":"Section of Hematology, Department of Medical Sciences Azienda Ospedaliero\u2010Universitaria Arcispedale S. Anna  Ferrara Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelina","family":"Dargenio","sequence":"additional","affiliation":[{"name":"Division of Hematology Hospital Vito Fazzi  Lecce Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8705-8333","authenticated-orcid":false,"given":"Cristina","family":"Papayannidis","sequence":"additional","affiliation":[{"name":"IRCCS Azienda Ospedaliero\u2010Universitaria di Bologna, Institute of Hematology, \u201cSer\u00e0gnoli\u201d  Bologna Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Mosna","sequence":"additional","affiliation":[{"name":"Hematology and Bone Marrow Transplantation Unit (BMTU) Hospital of Bolzano (SABES\u2010ASDAA), Teaching Hospital of Paracelsus Medical University (PMU)  Bolzano Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1355-1587","authenticated-orcid":false,"given":"Patrizia","family":"Chiusolo","sequence":"additional","affiliation":[{"name":"Hematology Unit, Department of Laboratory and Hematological Sciences Fondazione Policlinico Universitario A. Gemelli \u2013 IRCCS  Rome Italy"},{"name":"Department of Diagnostic Imaging, Radiotherapy Oncology and Hematology Catholic University of Sacred Heart  Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Guolo","sequence":"additional","affiliation":[{"name":"Hematology Unit, Department of Internal Medicine (DiMI), University of Genoa  Genoa Italy"},{"name":"IRCCS Hospital Policlinico San Martino  Genoa Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Buquicchio","sequence":"additional","affiliation":[{"name":"Hematology and Bone Marrow Transplant Unit Hospital Monsignor R. Dimiccoli  Barletta Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Cassanelli","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, Section of Hematology University of Modena and Reggio Emilia, Azienda Ospedaliero\u2010Universitaria di Modena  Modena Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Creti'","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, Section of Hematology University of Modena and Reggio Emilia, Azienda Ospedaliero\u2010Universitaria di Modena  Modena Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0716-1686","authenticated-orcid":false,"given":"Massimiliano","family":"Bonifacio","sequence":"additional","affiliation":[{"name":"Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine University of Verona  Verona Italy"},{"name":"Department of Medicine Azienda Ospedaliera Universitaria Integrata di Verona  Verona Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3721-5403","authenticated-orcid":false,"given":"Felicetto","family":"Ferrara","sequence":"additional","affiliation":[{"name":"Hematology Unit Hospital \u201cAntonio Cardarelli\u201d  Naples Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Pizzolo","sequence":"additional","affiliation":[{"name":"Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine University of Verona  Verona Italy"},{"name":"Department of Medicine Azienda Ospedaliera Universitaria Integrata di Verona  Verona Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5021-3026","authenticated-orcid":false,"given":"Robin","family":"Fo\u00e0","sequence":"additional","affiliation":[{"name":"Hematology, Department of Translational and Precision Medicine \u201cSapienza\u201d University of Rome  Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4436-1310","authenticated-orcid":false,"given":"Anna","family":"Candoni","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, Section of Hematology University of Modena and Reggio Emilia, Azienda Ospedaliero\u2010Universitaria di Modena  Modena Italy"},{"name":"Hematology Section, Department of Internal Medicine Ca' Foncello Hospital  Treviso Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Luppi","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, Section of Hematology University of Modena and Reggio Emilia, Azienda Ospedaliero\u2010Universitaria di Modena  Modena Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1354-3659","authenticated-orcid":false,"given":"Anna Maria","family":"Testi","sequence":"additional","affiliation":[{"name":"Hematology, Department of Translational and Precision Medicine \u201cSapienza\u201d University of Rome  Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023023568"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2025018736"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006469"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01351"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2026.101397"},{"key":"e_1_2_10_7_1","article-title":"Intensification of Induction and Consolidation Improves Only Subgroups of Adult ALL: Analysis of 1200 Patients in GMALL Study 05\/93","volume":"98","author":"Goekbuget N.","year":"2001","journal-title":"Blood"},{"key":"e_1_2_10_8_1","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1200\/JCO.2007.13.7265","article-title":"Comparison of the Results of the Treatment of Adolescents and Young Adults With Standard\u2010Risk Acute Lymphoblastic Leukemia With the Programa Espanol de Tratamiento en Hematologia Pediatric\u2010Based Protocol ALL\u201096","volume":"26","author":"Ribera J. M.","year":"2008","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"e_1_2_10_9_1","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1200\/JCO.2008.18.6916","article-title":"Pediatric\u2010Inspired Therapy in Adults With Philadelphia Chromosome\u2010Negative Acute Lymphoblastic Leukemia: The GRAALL\u20102003 Study","volume":"27","author":"Huguet F.","year":"2009","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_10_10_1","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V122.21.839.839","article-title":"Significant Improvement of Outcome in Adolescents and Young Adults (AYA) Aged 15\u201335\u2009Years With Acute Lymphoblastic Leukemia (ALL) With a Pediatric Derived Adult ALL Protocol: Results of 1529 AYAs in Two Consecutive Trials of the German Multicenter Study Group for Adult ALL (GMALL)","volume":"122","author":"Goekbuget N.","year":"2013","journal-title":"Blood"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2014.72"},{"key":"e_1_2_10_12_1","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/leu.2014.229","article-title":"Long\u2010Term Outcome of a Pediatric\u2010Inspired Regimen Used for Adults Aged 18\u201050\u2009Years With Newly Diagnosed Acute Lymphoblastic Leukemia","volume":"29","author":"DeAngelo D. J.","year":"2015","journal-title":"Leukemia"},{"key":"e_1_2_10_13_1","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/ajh.24419","article-title":"Final Results of a Single Institution Experience With a Pediatric\u2010Based Regimen, the Augmented Berlin\u2010Frankfurt\u2010M\u00fcnster, in Adolescents and Young Adults With Acute Lymphoblastic Leukemia, and Comparison to the Hyper\u2010CVAD Regimen","volume":"91","author":"Rytting M. E.","year":"2016","journal-title":"American Journal of Hematology"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13847"},{"key":"e_1_2_10_15_1","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/leu.2017.265","article-title":"Results of NOPHO ALL2008 Treatment for Patients Aged 1\u201345\u2009Years With Acute Lymphoblastic Leukemia","volume":"32","author":"Toft N.","year":"2018","journal-title":"Leukemia"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2017.76.8192"},{"key":"e_1_2_10_17_1","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2018-10-881961","article-title":"A Pediatric Regimen for Older Adolescents and Young Adults With Acute Lymphoblastic Leukemia: Results of CALGB 10403","volume":"133","author":"Stock W.","year":"2019","journal-title":"Blood"},{"key":"e_1_2_10_18_1","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/cam4.2814","article-title":"A Pediatric Regimen for Adolescents and Young Adults With Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia: Results of the ALLRE08 PETHEMA Trial","volume":"9","author":"Ribera J. M.","year":"2020","journal-title":"Cancer Medicine"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005576"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26066"},{"key":"e_1_2_10_21_1","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1182\/blood-2023-181014","article-title":"Updated Results on a Multicenter Phase II Study of a Dose Intensified Pediatric Regimen in Adults With Acute Lymphoblastic Leukemia: The 06\u2010254 DFCI ALL Consortium Trial","volume":"142","author":"Valtis Y. K.","year":"2023","journal-title":"Blood"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023009754"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375\u2010021\u201001460\u20106"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bneo.2024.100033"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.18502\/ijhoscr.v20i1.21010"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2026019616"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2023000510"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27607"},{"key":"e_1_2_10_29_1","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1182\/blood-2009-10-248146","article-title":"Molecular Response to Treatment Redefines All Prognostic Factors in Children and Adolescents With B Cell Precursor Acute Lymphoblastic Leukemia: Results in 3184 Patients of the AIEOP\u2010BFM ALL 2000 Study","volume":"115","author":"Conter V.","year":"2010","journal-title":"Blood"},{"key":"e_1_2_10_30_1","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1182\/blood-2013-10-532598","article-title":"Childhood High\u2010Risk Acute Lymphoblastic Leukemia in First Remission: Results After Chemotherapy or Transplant From the AIEOP ALL 2000 Study","volume":"123","author":"Conter V.","year":"2014","journal-title":"Blood"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bneo.2025.100111"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277\u2010023\u201005151\u20103"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2025.07.006"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2025.1962"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40801\u2010025\u201000538\u20102"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.72094"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022009596"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024027500"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2024.285638"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023020794"},{"issue":"3","key":"e_1_2_10_41_1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/leu.2009.268","article-title":"Standardized MRD Quantification in European ALL Trials: Proceedings of the Second International Symposium on MRD Assessment in Kiel, Germany, 18\u201020 September 2008","volume":"24","author":"Bruggemann M.","year":"2010","journal-title":"Leukemia"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2026019628"},{"key":"e_1_2_10_43_1","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1182\/blood-2014-09-599894","article-title":"Role of Allogeneic Stem Cell Transplantation in Adult Patients With Ph\u2010Negative Acute Lymphoblastic Leukemia","volume":"125","author":"Dh\u00e9din N.","year":"2015","journal-title":"Blood"},{"key":"e_1_2_10_44_1","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/ajh.24285","article-title":"Pediatric\u2010Inspired Therapy Compared to Allografting for Philadelphia Chromosome\u2010Negative Adult ALL in First Complete Remission","volume":"91","author":"Seftel M. D.","year":"2016","journal-title":"American Journal of Hematology"},{"key":"e_1_2_10_45_1","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1038\/s41375-021-01213-5","article-title":"Superior Survival With Pediatric\u2010Style Chemotherapy Compared to Myeloablative Allogeneic Hematopoietic Cell Transplantation in Older Adolescents and Young Adults With Ph\u2010Negative Acute Lymphoblastic Leukemia in First Complete Remission: Analysis From CALGB 10403 and the CIBMTR","volume":"35","author":"Wieduwilt M. J.","year":"2021","journal-title":"Leukemia"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023023153"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2024.286744"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.70103"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.70291"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2312948"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2026033309"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ejh.70317","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ejh.70317","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ejh.70317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:11:36Z","timestamp":1788873096000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ejh.70317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":50,"alternative-id":["10.1111\/ejh.70317"],"URL":"https:\/\/doi.org\/10.1111\/ejh.70317","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"2026-05-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"ejh.70317"}}